Concentra Group set the pricing of its U.S. initial public offering (IPO) at a valuation of $2.97 billion, the U.S. healthcare firm said on Wednesday.
Concentra Group, a Select Medical unit, is eyeing a valuation of $3.30 billion in its U.S. initial public offering, joining a growing list of firms testing the market after a near two-year dry spell.
Concentra Group Holdings Parent, Inc. has filed for a $100 million IPO, although the final amount may be substantially higher. The company provides occupational health and related services to employees in the U.S. CON is producing slow and decelerating revenue growth, leading to the possibility of a dull IPO.